Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Carcinoma (CRC) Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Not applicableLooking for participantsNCT07225309
What this trial is testing

Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center 300
Early research (Phase 1)Study completedNCT03295084
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors

Who this might be right for
Metastatic Colorectal Cancer
Dorte Nielsen 39
Not applicableStudy completedNCT03751384
What this trial is testing

Improvement of Compliance for High Doses of EPA Amongst Patients With Colorectal Cancer

Who this might be right for
ComplianceAbdominal Cancer
University of Copenhagen 41
Not applicableActive Not RecruitingNCT04136002
What this trial is testing

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Who this might be right for
Colorectal Cancer
Guardant Health, Inc. 44,467
Not applicableUnknownNCT04728139
What this trial is testing

Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Assiut University 90
Not applicableStudy completedNCT01405430
What this trial is testing

Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab

Who this might be right for
Colorectal CancerMetastasis
Centre Leon Berard 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05205330
What this trial is testing

Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers

Who this might be right for
Refractory Metastatic Colorectal CancerSolid TumorMetastatic Microsatellite-stable Colorectal Cancer+3 more
Rottapharm Biotech 107
Large-scale testing (Phase 3)Study completedNCT01001377
What this trial is testing

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Amgen 1,010
Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Testing effectiveness (Phase 2)UnknownNCT05970302
What this trial is testing

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

Who this might be right for
TislelizumabBevacizumabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Not applicableUnknownNCT06145230
What this trial is testing

A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups

Who this might be right for
Colorectal CancerAge Problem
Wang Guiyu 430
Testing effectiveness (Phase 2)UnknownNCT03093129
What this trial is testing

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)

Who this might be right for
Colorectal Cancer
The 108 Military Central Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Early research (Phase 1)Study completedNCT00291486
What this trial is testing

Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Ludwig Institute for Cancer Research 19
Not applicableStudy completedNCT02419586
What this trial is testing

Effectiveness of Gum Chewing on Ileus in Chinese Colorectal Patients Underwent Laparoscopic Colorectal Surgery

Who this might be right for
Colorectal Cancer
Shum Nga Fan 92
Testing effectiveness (Phase 2)UnknownNCT05866653
What this trial is testing

Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients

Who this might be right for
Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 90
Not applicableActive Not RecruitingNCT03451370
What this trial is testing

First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

Who this might be right for
Elderly Metastatic Colorectal Cancer Patients
Istituto Oncologico Veneto IRCCS 121
Large-scale testing (Phase 3)WithdrawnNCT01646554
What this trial is testing

Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Mutated Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableStudy completedNCT00499395
What this trial is testing

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 4
Next Page